Hematologic Response of Epoetin Alfa (PROCRIT) Versus Darbepoetin Alfa (ARANESP) in Chemotherapy Induced Anemia
Clinical trial NCT00315484 · COMPLETED
Trial details
- NCT number
- NCT00315484
- Sponsor
- Ortho Biotech Products, L.P.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2003-02-01
- Enrollment
- 358
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.